GenMark Diagnostics (GNMK) Posts Q4 Loss of 21c/Share

March 11, 2014 4:08 PM EDT Send to a Friend
GenMark Diagnostics (NASDAQ: GNMK) reported Q4 EPS of ($0.21), $0.01 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login